US Stock MarketDetailed Quotes

Solid Biosciences (SLDB)

Watchlist
  • 7.270
  • +0.200+2.83%
Close May 8 16:00 ET
  • 7.300
  • +0.030+0.41%
Post 19:28 ET
715.46MMarket Cap-3.65P/E (TTM)

Solid Biosciences (SLDB) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
38.14%179.21M
23.83%49.4M
36.60%48.06M
50.04%41.69M
49.10%40.05M
24.36%129.73M
79.19%39.9M
52.21%35.18M
3.28%27.79M
-16.13%26.86M
Selling and administrative expenses
16.77%38.88M
23.47%11.27M
17.08%9.2M
11.42%9.28M
14.38%9.14M
19.98%33.3M
33.97%9.13M
22.50%7.86M
16.80%8.33M
7.97%7.99M
-General and administrative expense
16.77%38.88M
23.47%11.27M
17.08%9.2M
11.42%9.28M
14.38%9.14M
19.98%33.3M
33.97%9.13M
22.50%7.86M
16.80%8.33M
7.97%7.99M
Research and development costs
45.52%140.33M
23.94%38.14M
42.21%38.86M
66.56%32.42M
63.80%30.91M
25.95%96.43M
99.12%30.77M
63.62%27.33M
-1.60%19.46M
-23.38%18.87M
Operating profit
-38.14%-179.21M
-23.83%-49.4M
-36.60%-48.06M
-50.04%-41.69M
-49.10%-40.05M
-24.36%-129.73M
-79.19%-39.9M
-52.21%-35.18M
-3.28%-27.79M
16.13%-26.86M
Net non-operating interest income expense
10.71%10.11M
10.65%2.05M
30.10%2.92M
17.32%2.91M
-12.68%2.23M
27.82%9.13M
11.51%1.85M
21.01%2.25M
27.09%2.48M
52.32%2.56M
Non-operating interest income
6.74%10.11M
6.34%2.05M
25.52%2.92M
15.63%2.97M
-13.24%2.3M
24.89%9.47M
9.38%1.93M
18.65%2.33M
24.51%2.57M
47.36%2.65M
Non-operating interest expense
----
----
----
-31.82%60K
-28.42%68K
-22.73%340K
-25.74%75K
-22.64%82K
-20.72%88K
-21.49%95K
Other net income (expense)
-27.53%-5.23M
46.58%-2.43M
-403.32%-640K
-389.96%-693K
-48,833.33%-1.46M
-453.89%-4.1M
-1,785.56%-4.55M
-24.10%211K
-27.13%239K
-98.94%3K
Gain on sale of security
-27.37%-6.05M
---2.65M
---850K
---900K
---1.65M
---4.75M
----
----
----
----
Special income (charges)
----
----
----
----
----
--0
--0
--0
--0
----
-Less:Restructuring and merger&acquisition
----
----
----
----
----
--0
--0
--0
--0
----
Other non- operating income (expenses)
26.38%824K
10.05%219K
-0.47%210K
-13.39%207K
6,166.67%188K
-40.46%652K
-26.30%199K
-24.10%211K
-9.81%239K
-98.94%3K
Income before tax
-39.80%-174.33M
-16.88%-49.79M
-39.88%-45.78M
-57.47%-39.48M
-61.63%-39.28M
-29.87%-124.7M
-109.47%-42.6M
-55.98%-32.73M
-1.80%-25.07M
19.18%-24.3M
Income tax
Net income
-39.80%-174.33M
-16.88%-49.79M
-39.88%-45.78M
-57.47%-39.48M
-61.63%-39.28M
-29.87%-124.7M
-109.47%-42.6M
-55.98%-32.73M
-1.80%-25.07M
19.18%-24.3M
Net income continuous Operations
-39.80%-174.33M
-16.88%-49.79M
-39.88%-45.78M
-57.47%-39.48M
-61.63%-39.28M
-29.87%-124.7M
-109.47%-42.6M
-55.98%-32.73M
-1.80%-25.07M
19.18%-24.3M
Minority interest income
Net income attributable to the parent company
-39.80%-174.33M
-16.88%-49.79M
-39.88%-45.78M
-57.47%-39.48M
-61.63%-39.28M
-29.87%-124.7M
-109.47%-42.6M
-55.98%-32.73M
-1.80%-25.07M
19.18%-24.3M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-39.80%-174.33M
-16.88%-49.79M
-39.88%-45.78M
-57.47%-39.48M
-61.63%-39.28M
-29.87%-124.7M
-109.47%-42.6M
-55.98%-32.73M
-1.80%-25.07M
19.18%-24.3M
Basic earnings per share
34.97%-1.99
48.04%-0.53
39.24%-0.48
31.15%-0.42
7.81%-0.59
36.65%-3.06
-2.00%-1.02
24.76%-0.79
51.20%-0.61
58.44%-0.64
Diluted earnings per share
34.97%-1.99
48.04%-0.53
39.24%-0.48
31.15%-0.42
7.81%-0.59
36.65%-3.06
-2.00%-1.02
24.76%-0.79
51.20%-0.61
58.44%-0.64
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 38.14%179.21M23.83%49.4M36.60%48.06M50.04%41.69M49.10%40.05M24.36%129.73M79.19%39.9M52.21%35.18M3.28%27.79M-16.13%26.86M
Selling and administrative expenses 16.77%38.88M23.47%11.27M17.08%9.2M11.42%9.28M14.38%9.14M19.98%33.3M33.97%9.13M22.50%7.86M16.80%8.33M7.97%7.99M
-General and administrative expense 16.77%38.88M23.47%11.27M17.08%9.2M11.42%9.28M14.38%9.14M19.98%33.3M33.97%9.13M22.50%7.86M16.80%8.33M7.97%7.99M
Research and development costs 45.52%140.33M23.94%38.14M42.21%38.86M66.56%32.42M63.80%30.91M25.95%96.43M99.12%30.77M63.62%27.33M-1.60%19.46M-23.38%18.87M
Operating profit -38.14%-179.21M-23.83%-49.4M-36.60%-48.06M-50.04%-41.69M-49.10%-40.05M-24.36%-129.73M-79.19%-39.9M-52.21%-35.18M-3.28%-27.79M16.13%-26.86M
Net non-operating interest income expense 10.71%10.11M10.65%2.05M30.10%2.92M17.32%2.91M-12.68%2.23M27.82%9.13M11.51%1.85M21.01%2.25M27.09%2.48M52.32%2.56M
Non-operating interest income 6.74%10.11M6.34%2.05M25.52%2.92M15.63%2.97M-13.24%2.3M24.89%9.47M9.38%1.93M18.65%2.33M24.51%2.57M47.36%2.65M
Non-operating interest expense -------------31.82%60K-28.42%68K-22.73%340K-25.74%75K-22.64%82K-20.72%88K-21.49%95K
Other net income (expense) -27.53%-5.23M46.58%-2.43M-403.32%-640K-389.96%-693K-48,833.33%-1.46M-453.89%-4.1M-1,785.56%-4.55M-24.10%211K-27.13%239K-98.94%3K
Gain on sale of security -27.37%-6.05M---2.65M---850K---900K---1.65M---4.75M----------------
Special income (charges) ----------------------0--0--0--0----
-Less:Restructuring and merger&acquisition ----------------------0--0--0--0----
Other non- operating income (expenses) 26.38%824K10.05%219K-0.47%210K-13.39%207K6,166.67%188K-40.46%652K-26.30%199K-24.10%211K-9.81%239K-98.94%3K
Income before tax -39.80%-174.33M-16.88%-49.79M-39.88%-45.78M-57.47%-39.48M-61.63%-39.28M-29.87%-124.7M-109.47%-42.6M-55.98%-32.73M-1.80%-25.07M19.18%-24.3M
Income tax
Net income -39.80%-174.33M-16.88%-49.79M-39.88%-45.78M-57.47%-39.48M-61.63%-39.28M-29.87%-124.7M-109.47%-42.6M-55.98%-32.73M-1.80%-25.07M19.18%-24.3M
Net income continuous Operations -39.80%-174.33M-16.88%-49.79M-39.88%-45.78M-57.47%-39.48M-61.63%-39.28M-29.87%-124.7M-109.47%-42.6M-55.98%-32.73M-1.80%-25.07M19.18%-24.3M
Minority interest income
Net income attributable to the parent company -39.80%-174.33M-16.88%-49.79M-39.88%-45.78M-57.47%-39.48M-61.63%-39.28M-29.87%-124.7M-109.47%-42.6M-55.98%-32.73M-1.80%-25.07M19.18%-24.3M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -39.80%-174.33M-16.88%-49.79M-39.88%-45.78M-57.47%-39.48M-61.63%-39.28M-29.87%-124.7M-109.47%-42.6M-55.98%-32.73M-1.80%-25.07M19.18%-24.3M
Basic earnings per share 34.97%-1.9948.04%-0.5339.24%-0.4831.15%-0.427.81%-0.5936.65%-3.06-2.00%-1.0224.76%-0.7951.20%-0.6158.44%-0.64
Diluted earnings per share 34.97%-1.9948.04%-0.5339.24%-0.4831.15%-0.427.81%-0.5936.65%-3.06-2.00%-1.0224.76%-0.7951.20%-0.6158.44%-0.64
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 7 Eastern Time, as the US-Iran negotiations entered a critical window amid external expectations and various parties' strategic maneu Show More